(April 23, 2021) Yesterday afternoon, the House of Representatives reintroduced H.R. 3, The Lower Drug Costs Now Act. While Easterseals is pleased that the House is looking at reducing drug costs for individuals across the country, we continue to be concerned that the bill, which relies on an International Pricing Index (IPI), will hurt the most vulnerable individuals for whom Easterseals and its national network of Affiliates care, including people with disabilities and those who are aging. The IPI system relies on the Quality – Adjusted Life Year (QALY) to determine the value of health care as defined by the person’s condition, which places less value on the lives of people with disabilities and/or people with chronic health conditions. Easterseals is willing to work with Congress to ensure that drug pricing policies do not negatively affect innovation, do not discriminate against vulnerable populations and represent the principles of health care equity. At a time when inequities are already a problem for many, there is no need to create additional barriers for people with the highest need for health care. Easterseals urges Congress to reject policies such as the use of QALYs and work with the disability, aging, and medical communities to ensure policies regarding care and treatment are fair and equitable.